{"entity":{"type":"insider","cik":"0001553594","url":"/insider/0001553594","json_url":"/insider/0001553594.json","name":"Fishman Corey N.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2013-02-14","last":"2023-11-20","span_basis":"filed_date"},"name_variants":[{"name":"Fishman Corey N.","source":"filing","n_filings":5,"first_seen":"2013-02-14","last_seen":"2023-11-20"}],"transactions":[{"id":8471176,"accession":"0001209191-23-056092","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-056092","line_url":"/filing/0001209191-23-056092#line-1","is_derivative":false,"issuer_cik":"0001553594","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001553594","owner_cik":"0001553594","owner_name":"Fishman Corey N.","owner_display_name":"Fishman Corey N.","owner_url":"/insider/0001553594","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.5863,"price_display":"1.59","price_state":"stated","total_value":15863.0,"total_display":"15,863.00","total_whole":"15,863","shares_owned_after":54449.0,"shares_owned_after_display":"54,449","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-20","filed_date":"2023-11-20","scope":"insider"},{"id":4083683,"accession":"0000899243-21-003521","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-003521","line_url":"/filing/0000899243-21-003521#line-2","is_derivative":false,"issuer_cik":"0001553594","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001553594","owner_cik":"0001553594","owner_name":"Fishman Corey N.","owner_display_name":"Fishman Corey N.","owner_url":"/insider/0001553594","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":85445.0,"shares_display":"85,445","price_per_share":1.73,"price_display":"1.73","price_state":"stated","total_value":147819.85,"total_display":"147,819.85","total_whole":"147,820","shares_owned_after":322008.0,"shares_owned_after_display":"322,008","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-26","filed_date":"2021-01-27","scope":"insider"},{"id":6000767,"accession":"0001209191-18-047711","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-047711","line_url":"/filing/0001209191-18-047711#line-1","is_derivative":false,"issuer_cik":"0001553594","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001553594","owner_cik":"0001553594","owner_name":"Fishman Corey N.","owner_display_name":"Fishman Corey N.","owner_url":"/insider/0001553594","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":8.7328,"price_display":"8.73","price_state":"stated","total_value":17465.6,"total_display":"17,465.60","total_whole":"17,466","shares_owned_after":239953.0,"shares_owned_after_display":"239,953","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-17","filed_date":"2018-08-21","scope":"insider"},{"id":6558426,"accession":"0001209191-18-034168","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-034168","line_url":"/filing/0001209191-18-034168#line-4","is_derivative":false,"issuer_cik":"0001553594","issuer_name":"Iterum Therapeutics plc","issuer_ticker":"ITRM","issuer_name_source":null,"issuer_url":"/issuer/0001553594","owner_cik":"0001553594","owner_name":"Fishman Corey N.","owner_display_name":"Fishman Corey N.","owner_url":"/insider/0001553594","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":39000.0,"total_display":"39,000.00","total_whole":"39,000","shares_owned_after":237953.0,"shares_owned_after_display":"237,953","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-30","filed_date":"2018-05-30","scope":"insider"},{"id":4767681,"accession":"0001181431-13-009834","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-009834","line_url":"/filing/0001181431-13-009834#line-1","is_derivative":false,"issuer_cik":"0001544116","issuer_name":"Durata Therapeutics, Inc.","issuer_ticker":"DRTX","issuer_name_source":null,"issuer_url":"/issuer/0001544116","owner_cik":"0001553594","owner_name":"Fishman Corey N.","owner_display_name":"Fishman Corey N.","owner_url":"/insider/0001553594","role":"Officer (CFO & COO)","role_mark":"O","role_mark_label":"Officer (CFO & COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & COO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":22500.0,"total_display":"22,500.00","total_whole":"22,500","shares_owned_after":24941.0,"shares_owned_after_display":"24,941","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-24","filed_date":"2013-02-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001659323","name":"Iterum Therapeutics plc","url":"/issuer/0001659323","role":"Director, Officer (Chief Executive Officer)","n_filings":4,"first_seen":"2018-05-30","last_seen":"2023-11-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001544116","name":"Durata Therapeutics, Inc.","url":"/issuer/0001544116","role":"Officer (CFO & COO)","n_filings":1,"first_seen":"2013-02-14","last_seen":"2013-02-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001553594","retrieved_at":"2026-08-23T00:22:45+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}